VKH
ALPN

Virtu KCG Holdings’s Alpine Immune Sciences Inc ALPN Stock Holding History

Virtu KCG Holdings’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$29K Buy
+3,024
New +$29K ﹤0.01% 2687
2017
Q1 		– Sell
-3,640
Closed -$33K – 3867
2016
Q4 		$33K Buy
3,640
+649
+22% +$12.9K ﹤0.01% 3175
2016
Q3 		$97K Buy
+2,991
New +$72.8K ﹤0.01% 2646
2015
Q4 		– Sell
-4,008
Closed -$208K – 4026
2015
Q3 		$208K Buy
+4,008
New +$263K ﹤0.01% 2533

Other funds holding ALPN

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Virtu KCG Holdings's ALPN Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Alpine Immune Sciences Inc (ALPN) in Q2 2017: 3,024 shares worth $29K. The stake represents ﹤0.01% of the portfolio and ranks #2687 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in ALPN as recently as Q4 2016.

Virtu KCG Holdings first reported a position in ALPN in Q3 2015 and has held it in 4 quarters since. The position peaked at $208K in Q3 2015. 26 funds tracked by Wall St. Rank hold ALPN as of Q2 2017.

  • Virtu KCG Holdings held 3,024 shares of Alpine Immune Sciences Inc worth $29K as of Q2 2017.
  • Alpine Immune Sciences Inc was a new Virtu KCG Holdings position in Q2 2017.
  • Alpine Immune Sciences Inc made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2687 holding.
  • Virtu KCG Holdings first reported a position in Alpine Immune Sciences Inc in Q3 2015 and has held it in 4 quarters since.
  • Virtu KCG Holdings's Alpine Immune Sciences Inc position peaked at $208K in Q3 2015.
  • 26 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.